As time has gone on I’ve come to see many things in this
world that I identify as wrong or immoral. The marketing of deadly cigarettes
to minors is just one example. I want to
say something or propose a solution, but whatever I say, there will be
opposition, especially if it involves people’s livelihood.
Change only happens when you win over hearts and you come to
a tipping point. That’s not an easy thing to achieve. People resist change, human
nature being what it is. It took gay
rights advocates decades of advocacy to get where they are today.
I thought Pope Francis’s recent visit to the U.S. and his advocacy
for the poor was inspiring, I only wish more people were like him, striving for
humility and teaching by example. Unfortunately, a personage like the Pope is a
rarity.
I’m a realist. I understand
why our country’s founders worried about self-government. People can’t be
trusted to just do what is right. It’s
why we have a system of checks and balances and the separation of power in
government.
In the field of medicine, profit should never be the motive in
treating patients. That would be wrong. Yet,
I know we would never make any progress in improving medicine if there were not
some profit incentive in the healthcare system. I would not begrudge my
oncologist a penny, provided that he or she was recommending a course of
treatment that was necessary. I do, however, take exception to the inexplicably
high prices of life-saving drugs.
The most egregious case recently was Turing Pharmaceutical’s
purchase of the drug Daraprim, the only medication for treating toxoplasmosis,
an infection that can cause birth defects.
It’s a drug also used in combination with other drugs for HIV
infections, cancer and malaria. Turing
purchased the decades old drug and increased the price from $13.5 to $750 a tablet
– a 5000 percent increase! Not
surprisingly, it turns out that Turing’s CEO, Martin Shkreli, is a former
hedge-fund manager. Greed like this
makes me want to bring back tar and feathers. It’s just plainly wrong.
This month is breast cancer awareness month. It goes without
saying that I am very sympathetic to women who have breast cancer or any
cancer, for that matter. It seems to me,
however, that corporate support of breast cancer awareness is over the
top. Pink is everywhere in the month of
October. You have to ask why the campaign is so successful?
Breast cancer advocates should be congratulated for coming up
with such a blockbuster idea to raise awareness. Enlisting corporate sponsors
is both profitable and effective. For
the corporate sponsor, being a supporter and putting a pink ribbon on something
you’re selling helps sell the product.
Corporations are not being altruistic when it comes to supporting breast
cancer, they are acting in their own self-interest and marketing to a powerful
consumer group – women.
I am getting ready for the SW Florida Lung Cancer 5K Run/Walk
and Mile of Memories walk scheduled for Charlotte Sports Park on November 7th. I am hoping we are going to have a record-breaking
crowd attending the event, but I expect to be disappointed.
For years I dreamed of filling the 5,000 seat stadium with lung
cancer supporters. Every year I despair
that we get a turnout of less than 1000 people.
The Susan G. Komen Race for the Cure at Coconut Point attracts nearly
10,000 runners and walkers and raises $1 million annually in funding.
Lung cancer kills roughly 35,000 Floridians every year. In
Charlotte County alone it is estimated that we lost 460 people to lung cancer last
year. Victims of lung cancer are fighting for their life; they are not
available to serve on a fundraising committee or walk or run in a race. They are certainly not a consumer group that
has much marketing merit for corporate sponsors.
I haven’t found a way light a fire under people. But I know the difference between right and
wrong and I know that advocating for lung cancer, the leading cause of cancer
death, is right, even if it is not popular.
No comments:
Post a Comment